Product
Information
ROWASA® (Mesalamine) Enema is first-line therapy
for fast, effective management of symptoms associated
with active, mild to moderate distal ulcerative colitis,
proctosigmoiditis, or ulcerative proctitis.
ROWASA is the only branded
mesalamine suspension formulation for rectal use in
the United States.
Unlike orally-administered mesalamine,
ROWASA goes directly to the site of inflammation
(colon lining) to begin the healing process. Faster
healing means less bleeding and faster relief from diarrhea,
cramps, abdominal pain and bowel urgency.
ROWASA (Mesalamine) Rectal Suspension Enema
is indicated for the treatment of active mild to moderate
distal ulcerative colitis, proctosigmoiditis or proctitis.
ROWASA Rectal Suspension Enema
is usually well-tolerated. The most frequently
observed side effects include abdominal cramps, gas,
fever, flu symptoms, and leg/joint pain.
ROWASA Enema is contraindicated
for patients known to have hypersensitivity to the drug
or any component of this medication.
Caution should be exercised when
mesalamine is initially used in patients known to be
allergic to sulfasalazine.
ROWASA Enema is available by prescription
only. Ask your doctor if ROWASA Enema is
right for you.
About This
Disease
Ulcerative colitis (UC) and
ulcerative proctitis (UP) are diseases that affect the
colon, also called the large intestine. In UC and UP,
the lining of the colon walls becomes inflamed and marked
by small crater-like holes, or ulcers, that prevent
the colon from doing an efficient job of separating
nutrients, reabsorbing water, and passing waste. One
difference between UC and UP is the area of colon affected.
In UC, inflammation and ulcers are found on the lining
of the rectum and can extend to include the entire colon.
In UP, a form of ulcerative colitis, inflammation is
limited to the rectum.
The type and severity of symptoms
you experience will depend on the amount of colon that
is inflamed and the progression of your disease. The
most common symptoms associated with mild-to-moderate
UC are: diarrhea, constipation, tenesmus, stomach cramps,
rectal bleeding, stool coated in blood and/or mucus,
mild weight loss and low-grade fever. There are approximately
500,000 Americans with ulcerative colitis.
Currently, there is no medicinal
cure for ulcerative colitis. Treatment of UC mainly
involves the use of medications to relieve symptoms
such as inflammation, diarrhea, rectal bleeding, and
abdominal pain and permit healing of the colon.
Availability
ROWASA Enema is available by
prescription only.
Ask your doctor if ROWASA Enema is right for you.
Reference Library
For questions about ROWASA Enema,
contact:rowasa@alavenpharm.com.
ROWASA® is a registered trademark of Alaven™ Pharmaceutical LLC.
|
